The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.
AbbVie has announced the European Commission (EC) has granted marketing authorization for ELAHERE (mirvetuximab soravtansine) ...
GlobalData on MSN17h
Roche secures CE mark for ovarian cancer detection testRoche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...
AbbVie says that Elahere is the first and only folate receptor alpha (FRÉ‘)-directed antibody drug conjugate (ADC) medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback